안과용 의약품 및 기기 시장 규모는 2024년에 570억 2,000만 달러로 평가되며 2032년에는 881억 8,000만 달러에 달할 것으로 예상되며, 2024-2032년 5.60%의 연평균 성장률을 보일 것으로 예상됩니다.
안과 질환 및 장애의 유병률 증가, 안과 질환에 대한 사람들의 건강 인식 증가, 강력한 분자 파이프라인의 존재, 안과용 의약품 및 기기의 채택 증가 등이 안과용 의약품 및 기기 세계 시장 성장을 크게 촉진하고 있습니다. 이 보고서는 안과용 의약품 및 기기 세계 시장에 대한 종합적인 평가를 제공합니다. 주요 부문, 동향, 시장 촉진요인, 억제요인, 경쟁 상황, 시장에서 중요한 역할을 하는 요인 등을 종합적으로 분석합니다.
안과용 의약품 및 기기 세계 시장 정의
안과는 안과 질환의 진단과 치료에 초점을 맞춘 의료 분야입니다. 안과용 장비는 백내장 수술, 녹내장 수술, 굴절 교정 수술 등 다양한 수술에 사용됩니다. 안과 치료는 감염, 녹내장, 백내장 등 다양한 안과 질환의 치료에 사용됩니다. 황반변성, 노안, 당뇨망막병증과 같은 안과 관련 질환의 유병률과 유병률이 노년층에서 증가함에 따라 세계 안과용 의약품 및 기기 시장은 크게 성장하고 있습니다. 정교한 안과 장비의 등장으로 사람들은 눈 관련 장애를 치료하기 위해 안과 수술을 선택하게 되었습니다.
안과용 의약품 및 기기 세계 시장 개요
안과용 의약품 및 기기 세계 시장은 노년층의 황반변성, 노안, 당뇨망막병증 등 다양한 안과 관련 질환을 치료하기 위한 최소침습 수술에 대한 수요가 증가함에 따라 향후 몇 년 동안 상당한 성장을 보일 것으로 예상됩니다. 안과 질환 및 장애의 발생률 및 유병률 증가, 안과 질환 및 장애에 대한 사람들의 건강 인식 증가, 강력한 분자 파이프라인의 존재, 특정 안구 기형 및 안구 결손의 치료 및 진단에 대한 안과 치료 및 장비의 채택 증가 등이 세계 안과 치료 및 장비 시장의 성장을 크게 촉진하고 있습니다.
또한, 안과용 의약품 및 기기 부문의 기술 발전과 새로운 안과 의약품 개발을 위한 연구 개발 활동에 대한 투자 증가도 시장 성장을 촉진하고 있습니다. 또한, 전 세계 노인 인구의 증가, 고혈당으로 인한 안과 질환의 증가, 헬스케어 부문의 성장, 진단 장비 및 치료 절차에 대한 자금 및 보조금 지원과 같은 형태로 정부의 노력과 지원의 증가도 안과용 의약품 및 기기 시장의 성장을 촉진하고 있습니다.
또한, 안과 관련 질환 환자 수 증가, 제품 개발 및 출시 활동 증가, 안구 내 렌즈 및 초음파 유화흡입장치에 대한 막대한 수요, 신흥국에서의 성장 잠재력 등은 예측 기간 동안 세계 안과용 의약품 및 기기 시장의 시장 참여자들에게 수익성 있는 성장 기회를 제공할 것으로 예상됩니다. 그러나 치료 시술에 따른 높은 비용, 여러 의약품이 개발 중인 가운데 의약품 승인 지연, 안과용 의약품에 대한 낮은 인지도, 숙련된 의료 인력 부족, 특허 만료 등은 예측 기간 동안 안과용 의약품 및 기기 시장의 성장을 저해할 것으로 예상됩니다. 또한, 안과 질환 치료에 따른 위험은 안과용 의약품 및 기기 시장의 성장에 도전이 되고 있습니다.
Ophthalmology Drugs And Devices Market size was valued at USD 57.02 Billion in 2024 and is projected to reach USD 88.18 Billion by 2032, growing at a CAGR of 5.60% from 2024 to 2032.
The increasing prevalence of eye diseases and disorders, rising health awareness among people about the same, presence of a robust pipeline of molecules, and increase in adoption of ophthalmology drugs and devices are driving the growth of the Global Ophthalmology Drugs And Devices Market significantly. The Global Ophthalmology Drugs And Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Ophthalmology Drugs And Devices Market Definition
Ophthalmology is a field of medical science that focuses on the diagnosis and treatment of eye disorders. Ophthalmic devices are used in a variety of procedures such as cataract surgery, glaucoma surgery, and refractive surgery. Ophthalmic drugs are used to treat a wide range of eye diseases, including infection, glaucoma, and cataract. The Global Ophthalmology Drugs And Devices Market is experiencing significant growth because of the rising incidence and prevalence of eye-related disorders such as macular degeneration, presbyopia, and diabetic retinopathy among the geriatric population. With the advent of sophisticated ophthalmic devices, people are increasingly going to opt for ophthalmic surgeries to cure their eye-related disorders.
Global Ophthalmology Drugs And Devices Market Overview
The Global Ophthalmology Drugs And Devices Market is expected to experience remarkable growth in the upcoming years owing to the increasing demand for minimally invasive surgeries in the treatment of various eye-related disorders such as macular degeneration, presbyopia, and diabetic retinopathy among the geriatric population. The increasing incidence and prevalence of eye diseases and disorders, rising health awareness among people about the same, presence of a robust pipeline of molecules, and increase in adoption of ophthalmology drugs and devices in the treatment and diagnosis of certain ocular malformations and eye deficits are fueling the growth of Global Ophthalmology Drugs And Devices Market significantly.
Additionally, technological advancement in the field of Ophthalmology Drugs and Devices and increasing investment in R&D activities for the development of new ophthalmological drugs are also promoting market growth. Furthermore, the rise in the geriatric population across the globe, increasing ophthalmic disorders due to high blood sugar, growth in the healthcare sector, and increasing government initiatives and support in the form of funds and grants for diagnostic equipment and treatment procedures, also boost the growth of the Ophthalmology Drugs And Devices Market.
Moreover, an increase in the patient population of eye-related disorders, increasing product development and launch activities, huge demand for intraocular lenses and phacoemulsification devices, and growth potential in developing nations are expected to provide profitable growth opportunities to the market players in the Global Ophthalmology Drugs And Devices Market during the forecast period. However, high cost associated with the treatment procedures, drug approval delays wherein multiple drugs are in the pipeline, low awareness of ophthalmic drugs, lack of skilled healthcare professionals, and patent expiry is expected to hinder the growth of the Global Ophthalmology Drugs And Devices Market over the forecast period. In addition, risks associated with ocular disease treatment are posing challenges to the growth of the Ophthalmology Drugs And Devices Market.
The Global Ophthalmology Drugs And Devices Market is Segmented on the basis of Product Type, Application, End-User, and Geography.
Based on Product Type, the market is bifurcated into Anti-allergy, Anti-Vascular Endothelial Growth Factor (Anti-VEGF) agents, Anti-inflammatory, Anti-glaucoma, Diagnostic and Monitoring Devices, Surgical Devices, Vision Care, and Others. The anti-inflammatory segment accounts for the highest revenue share of the Global market in 2020 and is expected to dominate the market over the forecast period owing to an increase in the prevalence of allergic conjunctivitis and hypersensitivity reactions, as well as an increase in demand for anti-inflammatory drugs in a wide range of conditions such as uveitis, cystoid macular edema, and scleritis. These factors are driving the growth of this segment.
Based on Application, the market is bifurcated into Dry Eye, Eye Allergy, Glaucoma, Cataract, Eye Infection, Retinal Disorders, Uveitis, and Others. The retinal disorders segment is expected to hold the largest revenue share of the global market during the forecast period owing to the rise in the geriatric population, increase in the prevalence of macular degeneration, and an increase in the sale of ophthalmic drugs for the treatment of retinal disorders. However, the glaucoma segment is expected to grow significantly during the forecast period due to an increase in glaucoma prevalence, a rising need for ophthalmic drugs, and an increase in glaucoma prevention and treatment awareness.
Based on End-User, the market is bifurcated into Hospitals, Medical Clinics, Diagnostic Centers, and Others. The hospitals segment is expected to grow at the highest CAGR during the forecast period owing to the increasing number of patients suffering from various eye-related disorders, and rising awareness about these disorders. Additionally, the availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled eye care professionals are driving the growth of the global market in the hospitals segment.
The "Global Ophthalmology Drugs And Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Carl Zeiss AG, Novartis AG, Johnson And Johnson Services, Inc., Allergan, Topcon Corporation, Nidek Co., Ltd., HAAG-STREIT GROUP, Ziemer Ophthalmic Systems, Bausch And Lomb Incorporated, Biotech, VisionCare, Inc., Akorn, Incorporated, Bayer AG, Acucela Inc., Regeneron Pharmaceuticals, Inc, Nicox, Santen Pharmaceutical Co., Ltd. and IRIDEX Corporation, Alcon Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.